Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown(Mayo Clinic in Arizona), Karla V. Ballman(Alliance Data (United States)), Jane H. Cerhan(Mayo Clinic in Arizona), S. Keith Anderson(Alliance Data (United States)), Xiomara W. Carrero(Alliance Data (United States)), Anthony Whitton(Juravinski Cancer Centre), Jeffrey Greenspoon(Juravinski Cancer Centre), Ian F. Parney(Mayo Clinic in Arizona), Nadia N. Laack(Mayo Clinic in Arizona), Jonathan B. Ashman(WinnMed), Jean-Paul Bahary(Hôpital Notre-Dame), Costas G. Hadjipanayis(Mount Sinai Beth Israel), James J. Urbanic(University of California, San Diego), Fred G. Barker(Massachusetts General Hospital), Elana Farace(Pennsylvania State University), Deepak Khuntia(Varian Medical Systems (United States)), Caterina Giannini(Mayo Clinic in Arizona), Jan C. Buckner(Mayo Clinic in Arizona), Evanthia Galanis(Mayo Clinic in Arizona), David Roberge(Hôpital Notre-Dame)
Cited by 1,183Open Access
Abstract
Related Papers
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
Edward Shaw, Charles Scott, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k